Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Short term Debt (2022 - 2025)

PAVmed (PAVM) has 4 years of Short term Debt data on record, last reported at $6.9 million in Q3 2025.

  • For Q3 2025, Short term Debt changed N/A year-over-year to $6.9 million; the TTM value through Sep 2025 reached $6.9 million, changed N/A, while the annual FY2024 figure was $29.1 million, 34.16% down from the prior year.
  • Short term Debt reached $6.9 million in Q3 2025 per PAVM's latest filing, up from $6.8 million in the prior quarter.
  • Across five years, Short term Debt topped out at $45.5 million in Q1 2024 and bottomed at $260000.0 in Q2 2023.
  • Average Short term Debt over 4 years is $24.1 million, with a median of $29.3 million recorded in 2022.
  • Peak YoY movement for Short term Debt: crashed 99.18% in 2023, then soared 16823.08% in 2024.
  • A 4-year view of Short term Debt shows it stood at $33.6 million in 2022, then surged by 31.35% to $44.2 million in 2023, then crashed by 34.16% to $29.1 million in 2024, then plummeted by 76.29% to $6.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $6.9 million in Q3 2025, $6.8 million in Q2 2025, and $6.6 million in Q1 2025.